Delivery Order SPE2D020D0014-SPE2D325F6854
Award Date
2/24/25
Potential Completion Date
2/27/25
Potential Value
$2.8K
Federal Agency
Medical Supply Chain
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New York, NY 10001, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $5,640.00 firm fixed-price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Pfizer Inc., a global pharmaceutical corporation. The contract is for the delivery of 4,567,312,684 units of 4 mg/10 mL vials of the opioid overdose reversal drug Naloxone. The contract has a period of performance ending on February 24, 2025. This award is not associated with a set-aside program. Pfizer is the prime contractor and no subcontractors are mentioned. The Defense...
This federal contract award was issued by the Defense Logistics Agency Troop Support Medical, a defense agency, to Pfizer Inc., a global pharmaceutical corporation. The contract is for the delivery of Naloxone 0.4 mg/ml vials, a critical medication used to reverse opioid overdoses. The contract has a firm fixed price of $1,809.60 and a completion date of December 16, 2024. The contract was awarded without a set-aside designation, reflecting Pfizer's status as a large corporation. As a major...
This federal contract award to Pfizer Inc., valued at $8,460.00, is for the delivery of 4,566,739 vials of 4 mg/10 ml naloxone, an opioid overdose reversal medication. The contract was awarded by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense, without any set-aside designations. Pfizer, a large pharmaceutical manufacturer, is the prime contractor on this delivery order. The contract has an ultimate completion date of December 20, 2024. Pfizer also...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of NALOXONE 10MG/0.4ML, a critical pharmaceutical product, with a ceiling value of $11,763.28 and a period of performance through October 2023. The contract represents a task order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,622.99 contract is for the supply of NALOXONE 0.4 MG/ML, a medication used to reverse opioid overdoses. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, to the prime contractor Amerisourcebergen Drug Corp. The contract is for the procurement of 4,566,756,418 units of Naloxone 2 mg/2 ml syringes, a critical medication used to treat opioid overdose. The contract has a ceiling value of $1,557.70 and a period of performance through December 19, 2024. It is a firm-fixed-price delivery order contract,...
This federal contract award, valued at $3,903.43, was issued by the Medical Supply Chain agency of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.4 mg/ml naloxone vials, a critical medication used to treat opioid overdoses. The contract is a firm fixed-price delivery order with a completion date of June 27, 2024. While the original solicitation was not provided, the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4 mg Naloxone Hydrochloride nasal spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $1,630.20 and an ultimate completion date of January 30, 2025. This order is placed under a larger Indefinite Delivery Contract (IDC) held by...
This is a $4,993.14 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,565,056,293 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has an ultimate completion date of July 3, 2024 and was awarded on July 2, 2022. This delivery order is part of a larger Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to provide 4 mg/10 ml vials of the opioid overdose reversal medication naloxone. The contract has a ceiling value of $7,346.98 and a period of performance through May 4, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November...